Hytn Innovations Inc. Stock
€0.086
Your prediction
Financial data and news for Hytn Innovations Inc.
sharewise wants to provide you with the best news and tools for Hytn Innovations Inc., so we directly link to the best financial data sources.
Financials
News
HYTN Drug Establishment Licence Expanded to Include Active Pharmaceutical Ingredients and Pharmaceutical Oils
Vancouver, British Columbia – May 7th, 2026 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products
HYTN Successfully Exports GMP-Manufactured Vape Cartridges
VANCOUVER, British Columbia, April 30, 2026 -- HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products
HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business
Vancouver, British Columbia, April 23, 2026 - HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) ("HYTN" or the "Company") announces that its Board of Directors has approved the
HYTN Introduces HARd Remediation to GMP Processing Services, Releases Product in Germany
Vancouver, British Columbia, April 17, 2026 – HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC Pink: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products
HYTN Successfully Releases Cannabis Products in Germany and Accepts Reorder
VANCOUVER, British Columbia, March 27, 2026. HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in products
HYTN Appoints Fabian Monaco to Board of Directors
VANCOUVER, British Columbia - Mar 20, 2026 - HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis,